What is the CTXR stock price prediction for next 2 weeks?

According to our price prediction algorithm,Citius Pharmaceuticals, Inc. (CTXR) price will be around $1.00 in the next 2 weeks. This means it will decrease by -6.54205607476636 from the last closing price. This prediction may vary from other time period filters for CTXR stock.

What can be the highest Possible price of CTXR stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, CTXR can achieve the highest price of $1.19 which is 11.53458601732445 higher than last closing price. This prediction may vary from other time period filters for CTXR stock.

What can be the lowest Possible price of CTXR stock in next 2 weeks?

As per the forecast and algorithmic analysis, CTXR stock price can be as low as $0.81 which is -24.096400617800857 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for CTXR stock.

Will CTXR stock go high in the next 2 weeks?

No, our stock forecasting algorithm shows that CTXR stock will lose-6.54205607476636 in the next 2 weeks. This prediction may vary from other time period filters for CTXR stock.

What is CTXR stock last closing price?

Last closing price of CTXR stock was $1.07.

What is CTXR stock price prediction?

CTXR stock price prediction means predicting the future closing prices of CTXR stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of CTXR stock in a certain time period.

How we predict CTXR stock future prices?

If you are searching for CTXR stock forecast, analysis or price prediction, then you might be wondering what Citius Pharmaceuticals, Inc. (CTXR) will do in the future. Our CTXR price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This CTXR price prediction will likely answer most of your questions.

How frequent we update CTXR stock predictions?

We are updating the forecasts for the CTXR stock on daily basis.

Is using ML forecasting for CTXR stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for CTXR stock same for all the time periods?

No, the prediction for CTXR stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Citius Pharmaceuticals, Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$1.07-4.46%Since 2 Weeks

Predicted Price$1.00-6.54%For 2 Weeks

Upper Predicted Price$1.1911.53%For 2 Weeks

Lower Predicted Price$0.81-24.1%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of CTXR will decline by -6.54% over the next 2 Weeks and hit $1.00 by Friday, January 2, 2026. In that time frame, CTXR's share price is expected to range between $0.81 and $1.19.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Jan 2, 2026	0.81	1.00	1.19
Jan 1, 2026	0.77	0.96	1.13
Dec 31, 2025	0.78	0.97	1.16
Dec 30, 2025	0.82	1.01	1.19
Dec 29, 2025	0.80	0.99	1.19
Dec 26, 2025	0.85	1.03	1.23
Dec 25, 2025	0.80	0.99	1.17
Dec 24, 2025	0.83	1.00	1.20
Dec 23, 2025	0.86	1.04	1.24
Dec 22, 2025	0.84	1.03	1.22

CTXR shares fell -1.40% in Monday, December 22, 2025's trading session, dropping from a previous close of $1.07 to move at $1.06. The stock demonstrated notable intraday movement (see CTXR's key stats for a full breakdown), fluctuating between $1.05 and $1.09, a +3.81% trading range. While recent weeks have seen some volatility, CTXR has managed to secure a -10.59% drop over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 233.47K shares changing hands, 3.81K fewer than the previous session. This amounted to $246.31K in total market activity.

Will CTXR Continue Its Upward Trend?

According to analyst ratings and projections for CTXR, Citius Pharmaceuticals, Inc. shares are anticipated to increase by +11.32%, potentially reaching $1.19 per share by January 2, 2026. Short-term technical indicators currently suggest a neutral sentiment for CTXR. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 11 positive trading days within the past 30 sessions. Based on the CTXR stock forecast, now is a good time to buy CTXR stock because its current trading price is +5.50% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on CTXR covering social and institutional perspectives.

CTXR Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into CTXR's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 41.52% to 44.16%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 46.24%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 44.61%, maintains a neutral outlook for the long term. Insights into CTXR's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Citius Pharmaceuticals Short-Term Forecasts

CTXR Forecast For Next 5 Days

Our algorithm anticipates Citius Pharmaceuticals (CTXR) stock could hit $0.99 by Dec 29, 2025. This represents a -6.54% fall from today's price, following a -7.76% change over the past five days.

CTXR Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Citius Pharmaceuticals, Inc. (CTXR) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.91, which would mean a -13.74% decrease from the current price of $1.06. Projections for this period range from a high of $1.48 to a low of $0.51.

CTXR Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Citius Pharmaceuticals's price over the next three months point to a rise. CTXR stock is expected to peak at $2.48 on Mar 20, 2026 after potentially dipping to $0.46 on Feb 17, 2026. On average, CTXR is likely to trade around $1.52 in the coming 90 days.

Citius Pharmaceuticals Stock Forecast 2025

Based on our predictive models, Citius Pharmaceuticals (CTXR) is expected to trade between $1.11 and $2.15 throughout 2025. This would result in an average price of $1.60, potentially offering investors a +51.66% return from current levels.

Citius Pharmaceuticals, Inc. Monthly Forecast 2025–2026

December 2025

According to our latest forecast models, Citius Pharmaceuticals, Inc. (CTXR) is positioned to show a strong performance in December 2025. The price is predicted to move between $1.11 and $2.15, settling at an average of $1.60. This could translate to a +51.66% gain.

January 2026

Based on current market signals, Citius Pharmaceuticals, Inc. is projected to trend january 2026. We forecast a trading range from $1.13 to $2.38, with a likely average price of $1.73. Investors could expect a potential return of +63.98%.

February 2026

Our predictive algorithms indicate Citius Pharmaceuticals, Inc. stock may see a shift in February 2026. The expected range spans $0.46–$1.86, with an average target of $1.10. This represents a positive outlook and a possible gain of +4.27%.

March 2026

Analyzing established trends, Citius Pharmaceuticals, Inc. looks set to move in March 2026. Projections place the stock between $0.98 and $3.11, averaging around $1.93. This suggests a +82.94% gain from current levels.

April 2026

Market indicators suggest Citius Pharmaceuticals, Inc. could experience notable changes during April 2026. Prices could fluctuate within $1.05 to $3.00, with a midpoint forecast of $2.20. The stock might deliver a +108.53% gain.

May 2026

Forecasting for May 2026, models estimate that Citius Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.93 and $2.80, averaging $2.13. This signals a positive trajectory with potential returns around +101.90%.

June 2026

According to our latest forecast models, Citius Pharmaceuticals, Inc. (CTXR) is positioned to show a strong performance in June 2026. The price is predicted to move between $0.65 and $2.91, settling at an average of $2.62. This could translate to a +148.34% gain.

July 2026

Based on current market signals, Citius Pharmaceuticals, Inc. is projected to trend july 2026. We forecast a trading range from $0.00 to $2.14, with a likely average price of $2.11. Investors could expect a potential return of +100.00%.

August 2026

Our predictive algorithms indicate Citius Pharmaceuticals, Inc. stock may see a shift in August 2026. The expected range spans $0.00–$1.94, with an average target of $2.87. This represents a positive outlook and a possible gain of +172.04%.

September 2026

Analyzing established trends, Citius Pharmaceuticals, Inc. looks set to move in September 2026. Projections place the stock between $0.00 and $1.52, averaging around $1.83. This suggests a +73.46% gain from current levels.

October 2026

Market indicators suggest Citius Pharmaceuticals, Inc. could experience notable changes during October 2026. Prices could fluctuate within $0.00 to $0.71, with a midpoint forecast of $2.04. The stock might deliver a +93.36% gain.

November 2026

Forecasting for November 2026, models estimate that Citius Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.25, averaging $2.03. This signals a positive trajectory with potential returns around +92.42%.

December 2026

According to our latest forecast models, Citius Pharmaceuticals, Inc. (CTXR) is positioned to show a strong performance in December 2026. The price is predicted to move between $0.00 and $0.22, settling at an average of $1.00. This could translate to a -5.21% loss.

CTXR's history of dividends and stock splits also plays a role in long-term investor confidence.